Press "Enter" to skip to content

New patent for Janssen Pharms drug SPRAVATO

0
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug SPRAVATO

Annual Drug Patent Expirations for SPRAVATO
Annual Drug Patent Expirations for SPRAVATO

Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has twenty patent family members in ten countries.

The generic ingredient in SPRAVATO is esketamine hydrochloride. One supplier is listed for this compound. Additional details are available on the esketamine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug SPRAVATO
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions